Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 1,203 $ 1,193 $ 4,732 $ 2,456
Operating expenses        
Research and development (28,211) (24,067) (81,585) (65,791)
General and administrative (15,173) (13,001) (42,529) (32,557)
Total operating expenses (43,384) (37,068) (124,114) (98,348)
Operating loss (42,181) (35,875) (119,382) (95,892)
Interest income 225 2,147 916 4,024
Other income (expense), net (237) (1,689) (184) (1,501)
Loss before income taxes (42,193) (35,417) (118,650) (93,369)
Income taxes (208) (15) (582) (110)
Net loss attributable to ordinary shareholders $ (42,401) $ (35,432) $ (119,232) $ (93,479)
Net loss per ordinary share        
Basic and diluted (in dollars per share) $ (0.05) $ (0.04) $ (0.13) $ (0.11)
Weighted average shares outstanding:        
Basic and diluted (in shares) 936,600,648 928,022,057 933,992,708 829,973,177